As a firm, Dolor Therapeutics, LLC is structured around developing optimized oral therapies for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), a prevalent urological condition with no current FDA-approved treatments. The approach being utilized involves formulation of combination of mast cell stabilizers and histamine receptor antagonists into a user-friendly soft-gel capsule to improve absorption and patient adherence. In collaboration with formulation experts and academic partners, management are tackling development of advanced effective, accessible treatments for men affected by CP/CPPS."
